{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:10:37Z","timestamp":1782789037197,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gyrate atrophy of the choroid and retina (GACR) is a rare amino acid metabolism disorder. Night blindness, cataracts, vision loss, and impaired cognitive functions can be seen. An arginine-restricted diet, combined with pyridoxine, lysine, proline, or creatine supplementation, can be used in conjunction with treatments for ophthalmological findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients followed by the Gazi University Faculty of Medicine, Department of Pediatric Metabolism and Nutrition, and Department of Ophthalmology who were genetically or biochemically diagnosed with GACR were included in the study. The patients\u2019 medical records were retrospectively reviewed between 2000 and 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven patients with a mean age of 18.08\u2009\u00b1\u20098.6 years and a mean age at diagnosis of 10.4\u2009\u00b1\u20095.6 years were included. The earliest diagnosed patient was 15 months old. All patients had high plasma ornithine levels at the time of diagnosis, and they were all started on an arginine-restricted diet. Ophthalmological treatments were decided on a patient-specific basis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GACR is easily recognizable, but there is still no consensus on treatment modalities. The patients primarily present with progressive ophthalmological findings. An arginine-restricted diet is combined with supplementation with pyridoxine, lysine, proline, or creatine to improve metabolic control. Ophthalmological treatments are mainly applied to reduce cystoid macular edema. Early diagnosis and early initiation of therapy should be aimed at patients, and a multidisciplinary approach should be demonstrated both in diagnosis and follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04265-x","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T11:06:21Z","timestamp":1771239981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gyrate atrophy of the choroid and retina: a tertiary center experience"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3735-7439","authenticated-orcid":false,"given":"Ekin \u00d6zsayd\u0131","family":"Akta\u015fo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin Baran","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet C\u00fcneyt","family":"\u00d6zmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131","family":"\u0130nci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lyas","family":"Okur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih S\u00fcheyl","family":"Ezg\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"T\u00fcmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"1\u20132","key":"4265_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymgme.2021.07.010","volume":"134","author":"BM Balfoort","year":"2021","unstructured":"Balfoort BM, Buijs MJN, ten Asbroek ALMA, et al. A review of treatment modalities in gyrate atrophy of the choroid and retina (GACR). Mol Genet Metab. 2021;134(1\u20132):96\u2013116.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4265_CR2","doi-asserted-by":"publisher","first-page":"140555","DOI":"10.1016\/j.bbapap.2020.140555","volume":"1869","author":"R Montioli","year":"2021","unstructured":"Montioli R, Bellezza I, Desbats MA, et al. Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects. Biochim Biophys Acta - Proteins Proteom. 2021;1869(1):140555.","journal-title":"Biochim Biophys Acta - Proteins Proteom"},{"issue":"4","key":"4265_CR3","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.3390\/ijms24043369","volume":"24","author":"F Floriani","year":"2023","unstructured":"Floriani F, Borri Voltattorni C, Cellini B, Montioli R. Biochemical and bioinformatic studies of mutations of residues at the Monomer\u2013Monomer interface of human ornithine aminotransferase leading to gyrate atrophy of choroid and retina. Int J Mol Sci. 2023;24(4):3369.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4265_CR4","first-page":"365","volume":"42","author":"V Ramesh","year":"1988","unstructured":"Ramesh V, Benoit LA, Crawford P, et al. The ornithine aminotransferase (OAT) locus: analysis of RFLPs in gyrate atrophy. Am J Hum Genet. 1988;42(2):365\u201372.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"4265_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1620\/tjem.205.335","volume":"205","author":"Y Ohkubo","year":"2005","unstructured":"Ohkubo Y, Ueta A, Ito T, et al. Vitamin B6-Responsive ornithine aminotransferase deficiency with a novel mutation G237D. Tohoku J Exp Med. 2005;205(4):335\u201342.","journal-title":"Tohoku J Exp Med"},{"issue":"5","key":"4265_CR6","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1016\/S0021-9258(19)50731-1","volume":"267","author":"LC Brody","year":"1992","unstructured":"Brody LC, Mitchell GA, Obie C, et al. Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences. J Biol Chem. 1992;267(5):3302\u20137.","journal-title":"J Biol Chem"},{"issue":"3","key":"4265_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1203\/00006450-199809000-00019","volume":"44","author":"K Hein\u00e4nen","year":"1998","unstructured":"Hein\u00e4nen K, N\u00e4nt\u00f6-Salonen K, Leino L, et al. Gyrate atrophy of the choroid and retina: lymphocyte Ornithine-\u03b4-Aminotransferase activity in different mutations and carriers. Pediatr Res. 1998;44(3):381\u20135.","journal-title":"Pediatr Res"},{"issue":"4","key":"4265_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0161-6420(81)35031-3","volume":"88","author":"KK Takki","year":"1981","unstructured":"Takki KK, Milton RC. The natural history of gyrate atrophy of the choroid and retina. Ophthalmology. 1981;88(4):292\u2013301.","journal-title":"Ophthalmology"},{"issue":"5","key":"4265_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10545-005-0074-1","volume":"28","author":"MA Cleary","year":"2005","unstructured":"Cleary MA, Dorland L, de Koning TJ, et al. Ornithine aminotransferase deficiency: diagnostic difficulties in neonatal presentation. J Inherit Metab Dis. 2005;28(5):673\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"4265_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ng1095-185","volume":"11","author":"T Wang","year":"1995","unstructured":"Wang T, Lawler AM, Steel G, et al. Mice lacking ornithine\u2013\u03b4\u2013amino\u2013transferase have Paradoxical neonatal hypoornithinaemia and retinal degeneration. Nat Genet. 1995;11(2):185\u201390.","journal-title":"Nat Genet"},{"issue":"1","key":"4265_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s44321-023-00001-1","volume":"16","author":"AA Bergen","year":"2023","unstructured":"Bergen AA, Buijs MJ, ten Asbroek AL, et al. Vision on gyrate atrophy: why treat the eye? EMBO Mol Med. 2023;16(1):4\u20137.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"4265_CR12","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1073\/pnas.97.3.1224","volume":"97","author":"T Wang","year":"2000","unstructured":"Wang T, Steel G, Milam AH, Valle D. Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci. 2000;97(3):1224\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4265_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-015-0242-9","volume":"10","author":"D Martinelli","year":"2015","unstructured":"Martinelli D, Diodato D, Ponzi E, et al. The hyperornithinemia\u2013hyperammonemia-homocitrullinuria syndrome. Orphanet J Rare Dis. 2015;10(1):29.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"4265_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1023\/A:1005602405349","volume":"22","author":"M Valtonen","year":"1999","unstructured":"Valtonen M, N\u00e4nt\u00f6-Salonen K, J\u00e4\u00e4skel\u00e4inen S, et al. Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia. J Inherit Metab Dis. 1999;22(8):855\u201366.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"4265_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ymgme.2008.12.010","volume":"97","author":"V Valayannopoulos","year":"2009","unstructured":"Valayannopoulos V, Boddaert N, Mention K, et al. Secondary creatine deficiency in ornithine delta-aminotransferase deficiency. Mol Genet Metab. 2009;97(2):109\u201313.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"4265_CR16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1046\/j.1365-2362.1999.00569.x","volume":"29","author":"K Hein\u00e4nen","year":"1999","unstructured":"Hein\u00e4nen K, N\u00e4nt\u00f6-Salonen K, Komu M, et al. Creatine corrects muscle 31 P spectrum in gyrate atrophy with hyperornithinaemia. Eur J Clin Invest. 1999;29(12):1060\u20135.","journal-title":"Eur J Clin Invest"},{"key":"4265_CR17","doi-asserted-by":"crossref","unstructured":"Boffa I, Polishchuk E, De Stefano L, et al. Liver-directed gene therapy for ornithine aminotransferase deficiency. EMBO Mol Med. 2023; 15(4).","DOI":"10.15252\/emmm.202217033"},{"issue":"10","key":"4265_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3928\/23258160-20240528-04","volume":"55","author":"A Sen","year":"2024","unstructured":"Sen A, Desai J, Sharma S, et al. Hyperreflective ganglion cell layer band in gyrate atrophy. Ophthalmic Surg Lasers Imaging Retina. 2024;55(10):598\u2013602.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"4265_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/humu.22233","volume":"34","author":"M Doimo","year":"2013","unstructured":"Doimo M, Desbats MA, Baldoin MC, et al. Functional analysis of missense mutations of OAT, causing gyrate atrophy of choroid and retina. Hum Mutat. 2013;34(1):229\u201336.","journal-title":"Hum Mutat"},{"issue":"7","key":"4265_CR20","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3390\/jcm13072079","volume":"13","author":"G Corradetti","year":"2024","unstructured":"Corradetti G, Verma A, Tojjar J, et al. Retinal imaging findings in inherited retinal diseases. J Clin Med. 2024;13(7):2079.","journal-title":"J Clin Med"},{"issue":"2","key":"4265_CR21","first-page":"253","volume":"38","author":"A Hasano\u011flu","year":"1996","unstructured":"Hasano\u011flu A, Bibero\u011flu G, T\u00fcmer L. Gyrate atrophy of the choroid and retina. Turk J Pediatr. 1996;38(2):253\u20136.","journal-title":"Turk J Pediatr"},{"issue":"7811","key":"4265_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(73)90667-3","volume":"301","author":"O Simell","year":"1973","unstructured":"Simell O, Takki K. Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet. 1973;301(7811):1031\u20133.","journal-title":"Lancet"},{"issue":"6","key":"4265_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1017\/S0007114511003291","volume":"106","author":"S Hayasaka","year":"2011","unstructured":"Hayasaka S, Kodama T, Ohira A. Retinal risks of high-dose ornithine supplements: a review. Br J Nutr. 2011;106(6):801\u201311.","journal-title":"Br J Nutr"},{"issue":"1","key":"4265_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13023-023-02840-0","volume":"18","author":"E Palmer","year":"2023","unstructured":"Palmer E, Stepien KM, Campbell C, et al. Clinical, biochemical and molecular analysis in a cohort of individuals with gyrate atrophy. Orphanet J Rare Dis. 2023;18(1):265.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"4265_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00006982-198909020-00014","volume":"9","author":"RB Feldman","year":"1989","unstructured":"Feldman RB, Mayo SS, Robertson DM, et al. Epiretinal membranes and cystoid macular edema in gyrate atrophy of the choroid and retina. Retina. 1989;9(2):139\u201342.","journal-title":"Retina"},{"issue":"4","key":"4265_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1023\/A:1005638004530","volume":"23","author":"K Peltola","year":"2000","unstructured":"Peltola K, Heinonen OJ, N\u00e4nt\u00f6-Salonen K, et al. Oral lysine feeding in gyrate atrophy with hyperornithinaemia \u2013 A pilot study. J Inherit Metab Dis. 2000;23(4):305\u20137.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"4265_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3341\/kjo.2013.27.5.388","volume":"27","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Lim DH, Kim JH, Kang SW. Gyrate atrophy of the choroid and retina diagnosed by Ornithine-\u03b4-aminotransferase gene analysis: A case report. Korean J Ophthalmol. 2013;27(5):388\u201391.","journal-title":"Korean J Ophthalmol"},{"issue":"11","key":"4265_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/bjo.58.11.907","volume":"58","author":"K Takki","year":"1974","unstructured":"Takki K, Simell O. Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia. Br J Ophthalmol. 1974;58(11):907\u201316.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"4265_CR29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1001\/archopht.122.7.982","volume":"122","author":"MI Kaiser-Kupfer","year":"2004","unstructured":"Kaiser-Kupfer MI, Caruso RC, Valle D, Reed GF. Use of an Arginine-Restricted diet to slow progression of visual loss in patients with gyrate atrophy. Arch Ophthalmol. 2004;122(7):982\u20134.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"4265_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.survophthal.2012.11.006","volume":"58","author":"S Salvatore","year":"2013","unstructured":"Salvatore S, Fishman GA, Genead MA. Treatment of cystic macular lesions in hereditary retinal dystrophies. Surv Ophthalmol. 2013;58(6):560\u201384.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"4265_CR31","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1167\/iovs.14-15995","volume":"56","author":"G Liew","year":"2015","unstructured":"Liew G, Moore AT, Webster AR, Michaelides M. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2015;56(3):1531\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"4265_CR32","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.5301\/ejo.5001010","volume":"27","author":"E Piozzi","year":"2017","unstructured":"Piozzi E, Alessi S, Santambrogio S, et al. Carbonic anhydrase inhibitor with topical NSAID therapy to manage cystoid macular edema in a case of gyrate atrophy. Eur J Ophthalmol. 2017;27(6):e179\u201383.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"4265_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00417-018-3953-5","volume":"256","author":"U Arslan","year":"2018","unstructured":"Arslan U, \u00d6zmert E, Demirel S, et al. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results. Graefe\u2019s Arch Clin Exp Ophthalmol. 2018;256(5):893\u2013908.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"4265_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.mito.2017.05.010","volume":"36","author":"BM Davis","year":"2017","unstructured":"Davis BM, Tian K, Pahlitzsch M, et al. Topical coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension. Mitochondrion. 2017;36:114\u201323.","journal-title":"Mitochondrion"},{"issue":"4","key":"4265_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/1120672119833271","volume":"30","author":"S Ekicier Acar","year":"2020","unstructured":"Ekicier Acar S, Sar\u0131cao\u011flu MS, \u00c7olak A, et al. Neuroprotective effects of topical coenzyme Q10\u2009+\u2009vitamin E in mechanic optic nerve injury model. Eur J Ophthalmol. 2020;30(4):714\u201322.","journal-title":"Eur J Ophthalmol"},{"issue":"13","key":"4265_CR36","doi-asserted-by":"publisher","first-page":"8295","DOI":"10.1167\/iovs.12-10374","volume":"53","author":"M Lulli","year":"2012","unstructured":"Lulli M, Witort E, Papucci L, et al. Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of Kainate-Induced retinal damage. Investig Opthalmology Vis Sci. 2012;53(13):8295.","journal-title":"Investig Opthalmology Vis Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04265-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04265-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04265-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:00:34Z","timestamp":1774353634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04265-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04265-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was planned according to the principles of the Declaration of Helsinki and approved by the Gazi University Ethics Commission (No: 2023\u2009\u2212\u20091523). The patients\u2019 medical records were retrospectively reviewed, and informed consent was not obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agreed for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}